Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice

ACS Chemical Biology

Volumn 9, Issue 1, 2014, Pages 266-275

  DiRaimondo, Thomas R ^a   Klock, Cornelius ^b   Warburton, Rod ^c   Herrera, Zachary ^b   Penumatsa, Krishna ^c   Toksoz, Deniz ^c   Hill, Nicholas ^c   Khosla, Chaitan ^a,b   Fanburg, Barry ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ETHYNYLBENZYL 2 [[( 3 BROMO 4,5 DIHYDROISOXAZOL 5 YL)METHYL]CARBAMOYL]PYRROLIDINE 1 CARBOXYLATE; 4 NITROPHENYL(QUINOLIN 3 YLMETHYL)CARBONATE; ACYLTRANSFERASE INHIBITOR; ERW 1041E; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; QUINOLIN 3 YLMETHYL 1H IMIDAZOLE 1 CARBOXYLATE; QUINOLIN 3 YLMETHYL 2 [[( 3 BROMO 4,5 DIHYDROISOXAZOL 5 YL)METHYL]CARBAMOYL] 4 (PROP 2 YN 1 YLOXY)PYRROLIDINE 1 CARBOXYLATE; QUINOLIN 3 YLMETHYL 2 [[( 3 BROMO 4,5 DIHYDROISOXAZOL 5 YL)METHYL]CARBAMOYL] 4 FLOUROPYRRIDINE 1 CARBOXYLATE; QUINOLIN 3 YLMETHYL 2 [[( 3 BROMO 4,5 DIHYDROISOXAZOL 5 YL)METHYL]CARBAMOYL] 4 FLOUROPYRROLIDINE 1 CARBOXYLATE; QUINOLIN 3 YLMETHYL 2 [[( 3 BROMO 4,5 DIHYDROISOXAZOL 5 YL)METHYL]CARBAMOYL]PYRROLIDINE 1 CARBOXYLATE; SEMAXANIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG HALF LIFE; DRUG SCREENING; DRUG SYNTHESIS; ELEVATED BLOOD PRESSURE; EXPERIMENTAL HYPERTENSION; EXPERIMENTAL PULMONARY HYPERTENSION; FLUORESCENCE MICROSCOPY; HEART RIGHT VENTRICLE PRESSURE; HYPOXIA; IN VIVO STUDY; LUNG; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANOXIA; ENZYME ACTIVATION; ENZYME INHIBITORS; GTP-BINDING PROTEINS; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MICE; MICE, INBRED C57BL; POSITRON-EMISSION TOMOGRAPHY; TRANSGLUTAMINASES;

EID: 84900459349     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb4006408     Document Type: Article

References (44)

1. Herve, P., Drouet, L., Dosquet, C., Launay, J. M., Rain, B., Simonneau, G., Caen, J., and Duroux, P. (1990) Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am. J. Med. 89, 117-120. (Pubitemid 20196727)
2. Herve, P., Launay, J. M., Scrobohaci, M. L., Brenot, F., Simonneau, G., Petitpretz, P., Poubeau, P., Cerrina, J., Duroux, P., and Drouet, L. (1995) Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med. 99, 249-254.
3. Kereveur, A., Callebert, J., Humbert, M., Herve, P., Simonneau, G., Launay, J. M., and Drouet, L. (2000) High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arter. Thromb. Vasc. Biol. 20, 2233-2239.
4. Sato, K., Webb, S., Tucker, A., Rabinovitch, M., OBrien, R. F., McMurtry, I. F., and Stelzner, T. J. (1992) Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am. Rev. Respir. Dis. 145, 793-797.
5. Dempsie, Y., and MacLean, M. R. (2008) Role of the serotonin transporter in pulmonary arterial hypertension. Expert Rev. Clin. Pharmacol. 1, 749-757.
6. Nemecek, G. M., Coughlin, S. R., Handley, D. A., and Moskowitz, M. A. (1986) Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc. Natl. Acad. Sci. U.S.A. 83, 674-678. (Pubitemid 16035536)
7. Lee, S. L., Wang, W. W., Lanzillo, J. J., and Fanburg, B. L. (1994) Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am. J. Physiol. 266, L46-52.
8. Kahn, A. M., Bishara, M., Cragoe, E. J., Allen, J. C., Seidel, C. L., Navran, S. S., ONeil, R. G., McCarty, N. A., and Shelat, H. (1992) Effects of serotonin on intracellular pH and contraction in vascular smooth muscle. Circ. Res. 71, 1294-1304.
9. Morecroft, I., Dempsie, Y., Bader, M., Walther, D. J., Kotnik, K., Loughlin, L., Nilsen, M., and MacLean, M. R. (2007) Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxiainduced pulmonary hypertension. Hypertension 49, 232-236. (Pubitemid 46360365)
10. Izikki, M., Hanoun, N., Marcos, E., Savale, L., Barlier-Mur, A. M., Saurini, F., Eddahibi, S., Hamon, M., and Adnot, S. (2007) Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am. J. Physiol.: Lung Cell. Mol. Physiol. 293, L1045-1052. (Pubitemid 47572253)
11. Abid, S., Houssaini, A., Chevarin, C., Marcos, E., Tissot, C.-M., Gary-Bobo, G., Wan, F., Mouraret, N., Amsellem, V., Dubois-Rande, J.-L., Hamon, M., and Adnot, S. (2012) Inhibition of gut-and lungderived serotonin attenuates pulmonary hypertension in mice. Am. J. Physiol.: Lung Cell. Mol. Physiol. 303, L500-508.
12. Ciuclan, L., Hussey, M. J., Burton, V., Good, R., Duggan, N., Beach, S., Jones, P., Fox, R., Clay, I., Bonneau, O., Konstantinova, I., Pearce, A., Rowlands, D. J., Jarai, G., Westwick, J., MacLean, M. R., and Thomas, M. (2013) Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression. Am. J. Respir. Crit. Care Med. 187, 78-89.
13. Eddahibi, S., Hanoun, N., Lanfumey, L., Lesch, K. P., Raffestin, B., Hamon, M., and Adnot, S. (2000) Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J. Clin. Invest. 105, 1555-1562. (Pubitemid 30390306)
14. Guignabert, C., Izikki, M., Tu, L. I., Li, Z., Zadigue, P., Barlier-Mur, A.-M., Hanoun, N., Rodman, D., Hamon, M., Adnot, S., and Eddahibi, S. (2006) Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ. Res. 98, 1323-1330. (Pubitemid 43948088)
15. Walther, D. J., Stahlberg, S., and Vowinckel, J. (2011) Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J. 278, 4740-4755.
16. Hummerich, R., Thumfart, J.-O., Findeisen, P., Bartsch, D., and Schloss, P. (2012) Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: evidence for a general mechanism of monoaminylation. FEBS Lett. 586, 3421-348.
17. Song, Y., Kirkpatrick, L. L., Schilling, A. B., Helseth, D. L., Chabot, N., Keillor, J. W., Johnson, G. V. W., and Brady, S. T. (2013) Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron 78, 109-123.
18. Liu, Y., Wei, L., Laskin, D. L., and Fanburg, B. L. (2011) Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 44, 548-555.
19. Wei, L., Warburton, R. R., Preston, I. R., Roberts, K. E., Comhair, S. a a, Erzurum, S. C., Hill, N. S., and Fanburg, B. L. (2012) Serotonylated fibronectin is elevated in pulmonary hypertension. Am. J. Physiol.: Lung Cell. Mol. Physiol. 302, L1273-1279.
20. Klock, C., and Khosla, C. (2012) Regulation of the activities of the mammalian transglutaminase family of enzymes. Protein Sci. 21, 1781-91.
21. Siegel, M., Strnad, P., Watts, R. E., Choi, K., Jabri, B., Omary, M. B., and Khosla, C. (2008) Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One 3, e1861.
22. Dafik, L., Albertelli, M., Stamnaes, J., Sollid, L. M., and Khosla, C. (2012) Activation and inhibition of transglutaminase 2 in mice. PLoS One 7, e30642.
23. Watts, R. E., Siegel, M., and Khosla, C. (2006) Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles. J. Med. Chem. 49, 7493-7501. (Pubitemid 44913408)
24. Pinkas, D. M., Strop, P., Brunger, A. T., and Khosla, C. (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 5, e327.
25. Stamnaes, J., Pinkas, D. M., Fleckenstein, B., Khosla, C., and Sollid, L. M. (2010) Redox regulation of transglutaminase 2 activity. J. Biol. Chem. 285, 25402-25409.
26. Jin, X., Stamnaes, J., Klock, C., DiRaimondo, T. R., Sollid, L. M., and Khosla, C. (2011) Activation of extracellular transglutaminase 2 by thioredoxin. J. Biol. Chem. 286, 37866-37873.
27. DiRaimondo, T. R., Plugis, N. M., Jin, X., and Khosla, C. (2013) Selective inhibition of extracellular thioredoxin by asymmetric disulfides. J. Med. Chem. 56, 1301-1310.
28. Ciuclan, L., Bonneau, O., Hussey, M., Duggan, N., Holmes, A. M., Good, R., Stringer, R., Jones, P., Morrell, N. W., Jarai, G., Walker, C., Westwick, J., and Thomas, M. (2011) A novel murine model of severe pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 184, 1171-1182.
29. Lorand, L., and Graham, R. M. (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 4, 140-156. (Pubitemid 36172696)
30. Dafik, L., and Khosla, C. (2011) Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2. Chem. Biol. 18, 58-66.
31. Staab, H. (1962) New methods of preparative organic chmistry IV. Syntheses using heterocyclic amides (azolides). Angew. Chem., Int. Ed. IV, 351-367.
32. DAddona, D., and Bochet, C. G. (2001) Preparation of carbamates from amines and alcohols under mild conditions. Tetrahedron Lett. 42, 5227-5229. (Pubitemid 32635133)
33. Gerig, J. T., and McLeod, R. S. (1973) Conformations of cisand trans-4-fluoro-L-proline in aqueous solution. J. Am. Chem. Soc. 95, 5725-5729.
34. Muszbek, L., Yee, V. C., and Hevessy, Z. (1999) Blood coagulation factor XIII: structure and function. Thromb. Res. 94, 271-305. (Pubitemid 29268348)
35. Mehta, K. (2005) Mammalian transglutaminases: a family portrait. Prog. Exp. Tumor Res. 38, 1-18.
36. Glaser, M., and Robins, E. G. (2009) Click labelling in PET radiochemistry. J. Labelled Compd. Radiopharm. 52, 407-414.
37. Rohloff, J. C., Robinson, J., III, and Gardner, J. O. (1992) Bromonitrile oxide [3 + 2] cycloadditions in water. Tetrahedron Lett. 33, 3113-3116.
38. Castelhano, A. L., Billedeau, R., Pliura, D. H., Bonaventura, B. J., and Krantz, A. (1988) Synthesis, chemistry, and absolute configuration of novel transglutaminase inhibitors containing a 3-halo-4,5-dihydroisoxazole. Bioorg. Chem. 16, 335-340.
39. Lee, D. W., Ha, H., and Lee, W. K. (2007) Selective mono-BOC protection of diamines. Synth. Commun. 37, 737-742. (Pubitemid 46294826)
40. Piper, J. L., Gray, G. M., and Khosla, C. (2002) High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry 41, 386-393. (Pubitemid 34049414)
41. Day, N., and Keillor, J. W. (1999) A continuous spectrophotometric linked enzyme assay for transglutaminase activity. Anal. Biochem. 274, 141-144. (Pubitemid 29466366)
42. Hausch, F., Halttunen, T., Maki, M., and Khosla, C. (2003) Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase. Chem. Biol. 10, 225-231. (Pubitemid 36380279)
43. Choi, K., Siegel, M., Piper, J. L., Yuan, L., Cho, E., Strnad, P., Omary, B., Rich, K. M., and Khosla, C. (2005) Chemistry and biology of dihydroisoxazole derivatives: Selective inhibitors of human transglutaminase 2. Chem. Biol. 12, 469-475. (Pubitemid 40588922)
44. Abramoff, M. D., Magalhaes, P. J., and Ram, S. J. (2004) Image processing with ImageJ. Biophotonics Int. 11, 36-42.